FindTrial
Sign In

Efficacy of Sanjeevani Vati in Infective Diarrhoea

A study on Sanjeevani Vati with special reference to Pharmaceutico-Analytical,In Vitro Anti Microbial effect on common Diarrhoeal pathogens and its clinical evaluation as empirical therapy in Infective Diarrhoea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035634
Enrollment
20
Registered
2021-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Principal RGGPG Ayurvedic College and Hospital Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.)Patients willing to go through trial. 2.)Patients of age group b/w 16-60 yrs of either sex. 3.)Clinically diagnosed and confirmed patients of infective Diarrhoea.

Exclusion criteria

Exclusion criteria: 1.)Patients below the age of 16yrs and above the age of 60 yrs. 2.)Patients with severe dehydration or suffering from AIDS,Cancer,TB,IBD.

Design outcomes

Primary

MeasureTime frame
Relief in symptoms in patients of Infective Diarrhoea.Timepoint: Duration of the treatment:It will be given for 5 days. Route of administration : Oral Follow up: After 5 days.—

Secondary

MeasureTime frame
General feeling of well beingTimepoint: 5 Days—

Countries

India

Contacts

Public ContactAnjali
drsthakur@gmail.com8894660999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026